EFPIA asked CRA to analyze existing national barriers preventing the adoption of joint reports on European relative efficacy assessments at launch (EU REA) and discuss solutions to foster the acceptance of joint reports at the national level. The project focused on nine EU countries and CRA engaged with the national trade associations in these markets to understand the barriers to using EU REA and potential solutions to overcome these barriers. This report, by Tim Wilsdon, Michele Pistollato, and Lilian Li, provides the main findings from discussions at a two-day workshop and is complemented by a set of slides with additional details. To read the report, click the link below.
Inequities in patient support, well-being, and treatment access for triple negative breast cancer patients
In this report, Charles River Associates (CRA) and Cancer Support Community (CSC) examine the extent to which policies associated with long-term support,...